Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Healthcare (NHC) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $15.7 million.

  • National Healthcare's Shares Outstanding (Diluted Average) fell 1.78% to $15.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year decrease of 1.78%. This contributed to the annual value of $15.6 million for FY2024, which is 143.84% up from last year.
  • According to the latest figures from Q3 2025, National Healthcare's Shares Outstanding (Diluted Average) is $15.7 million, which was down 1.78% from $15.6 million recorded in Q2 2025.
  • National Healthcare's Shares Outstanding (Diluted Average)'s 5-year high stood at $15.7 million during Q3 2024, with a 5-year trough of $15.3 million in Q3 2023.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $15.4 million (2021), whereas its average is $15.5 million.
  • Per our database at Business Quant, National Healthcare's Shares Outstanding (Diluted Average) crashed by 45.23% in 2023 and then surged by 217.19% in 2024.
  • Over the past 5 years, National Healthcare's Shares Outstanding (Diluted Average) (Quarter) stood at $15.4 million in 2021, then increased by 0.2% to $15.4 million in 2022, then dropped by 0.45% to $15.4 million in 2023, then rose by 1.44% to $15.6 million in 2024, then grew by 0.42% to $15.7 million in 2025.
  • Its last three reported values are $15.7 million in Q3 2025, $15.6 million for Q2 2025, and $15.6 million during Q1 2025.